SPL — Starpharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$53.53m
- AU$24.53m
- AU$4.21m
- 57
- 33
- 42
- 43
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 5.09 | 5.82 | 7.46 | 8.33 | 8.34 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.3 | -10.8 | -14.8 | -13.2 | -13.5 |
Capital Expenditures | -0.314 | -0.125 | -0.246 | -0.837 | -0.621 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.008 | 0 | 0 | 0.001 | 0.011 |
Sale/Maturity of Investment | |||||
Cash from Investing Activities | -0.306 | -0.125 | -0.246 | -0.836 | -0.61 |
Financing Cash Flow Items | — | — | -1.93 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.026 | -0.584 | 46.3 | 3.23 | -0.695 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -10.1 | -11.2 | 30.4 | -10.6 | -14.7 |